© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Diabetes
Majority of Diabetes Patients Would Adopt Remote Digital Monitoring
January 13, 2021
The findings are encouraging for future use of remote digital monitoring.
AHA: Fauci Says Long-term Follow Up Needed to Understand COVID-19 Effects
November 18, 2020
Dr. Anthony Fauci addresses the American Heart Association Scientific Sessions.
After Setbacks, Good News for Sotagliflozin in Heart Failure, CKD
November 17, 2020
After an FDA denial and a lost sponsor, sotagliflozin shows it can cut cardiovascular events and possibly treat a form of heart failure that has no approved therapies.
Anti-VEGF Therapy for Diabetic Retinopathy Gets to the Root Cause
September 14, 2020
Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this conclusion of a four-part video series.
Tackling Diabetes While Curbing Costs
July 23, 2020
Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.
Is Combination Therapy on the Horizon in Diabetic Macular Edema?
July 12, 2020
Patients with diabetic macular edema whose vision remains impaired even with the best available treatments may soon have a combination therapy.
Vascepa's Benefits For People With Diabetes Seen Amid Settlement of Patent Dispute
June 16, 2020
Results from REDUCE-IT trial presented at the ADA meeting show that the fish-oil pill is associated with cardiovascular disease protection among patients with diabetes.
Diabetes Management & Telehealth with Leslie Kolb
June 11, 2020
Association of Diabetes Care and Education Specialists, chief science and practice officer, Leslie Kolb chats with MHE Associate Editor Briana Contreras in MHE's newest podcast Tuning into the C-Suite about diabetes management and how it's affected by the use of telehealth, especially during the current and trying times of the COVID-19 pandemic.
Diabetes Self-Management in a COVID-19 World
June 01, 2020
Diabetes: The Quiet Epidemic That Is Not Going Away
April 13, 2020
Americans have been diagnosed with diabetes, mostly with the type 2 variety linked with being overweight or obese.
21st Century-Style Diabetes Disease Management: Coaches and Tech-Enabled
April 09, 2020
Several Blues plans have contracted with vendors that supply tech-enabled diabetes disease management and prevention programs. Sometimes the tech is combined with coaching - by a real, live human being.
Out-of-Pocket Costs for Diabetes Medicine Eliminated
January 31, 2020
New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.
Diabetes Drug Costs Drive Non-Adherence
November 11, 2019
A survey of diabetes educators reveals challenges faced by patients with diabetes who can’t afford their drugs.
Insulin Overutilization in Seniors with Type 2 Diabetes
October 18, 2019
As people with type 2 diabetes age, the risks of insulin use can outweigh its benefits, creating the need for increased provider and patient education.
Lack of Public Safe Disposal Options Causes Unease Among Diabetics
October 05, 2019
Study uncovers specific areas of care that cause concern for Americans with diabetes and opportunities for developing a plan of action.
Rate of New Diabetes Cases May Be Falling Globally
September 27, 2019
Downturn in incidence may be partially due to successful public health campaigns to prevent the disease.
How Member Engagement Increases Diabetes Outcomes
August 27, 2019
Offering rewards can be a great way to increase member engagement for patients with diabetes.
Early Intervention May Help Diabetes Patients
June 13, 2019
While aggressive early intervention may be useful for diabetes patients, that intervention must be sustained.
Top Challenges in Managing Diabetes
June 06, 2019
The leading problems that endocrinologists and educators see from their daily interactions with diabetes patients.